Benign Breast Disease in Women.

Background: Most clinical breast changes in women are benign; in only 3% to 6% of cases are they due to breast cancer. However, there is a lack of up-to-date, evidence-based treatment recommendations for the various benign differential diagnoses. Methods: Selective literature search of PubMed from 1...

Descripción completa

Detalles Bibliográficos
Publicado en:Deutsches Ärzteblatt International Vol. 116; no. 33/34; pp. 565 - 577
Autores principales: Stachs, Angrit, Stubert, Johannes, Reimer, Toralf, Hartmann, Steffi
Formato: Journal Article
Publicado: Deutscher Aerzte-Verlag GmbH 8/19/2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138763289&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 138763289
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        18660452
        5F0N
      jtl: Deutsches Ärzteblatt International
      issn: 18660452
      maglogo: N
    pubinfo:
      dt: 8/19/2019
      vid: 116
      iid: 33/34
      pid: 25312
      pub: Deutscher Aerzte-Verlag GmbH
    artinfo:
      ui:
        138763289
        10.3238/arztebl.2019.0565
        138763289
      ppf: 565
      ppct: 12
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Benign Breast Disease in Women.
      aug:
        au:
          Stachs, Angrit
          Stubert, Johannes
          Reimer, Toralf
          Hartmann, Steffi
        affil: Department of Obstetrics and Gynecology, University of Rostock
      sug:
      ab: Background: Most clinical breast changes in women are benign; in only 3% to 6% of cases are they due to breast cancer. However, there is a lack of up-to-date, evidence-based treatment recommendations for the various benign differential diagnoses. Methods: Selective literature search of PubMed from 1985 to May 2019, including current national (AWMF, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften [Association of Scientific Medical Societies in Germany]) and international guidelines. Results: Mastalgia and fibrocystic changes are common (around 50% of all women over the age of 30). Fibroadenomas occur in 25% of women; they are the most common benign tumors of the breast and do not require treatment. With most benign breast changes the risk of dedifferentiation is very low. However, it is important in the differential diagnosis to distinguish between such benign changes and breast cancer or changes that carry a risk of malignancy. Complex cysts, for example, carry a risk of malignancy of 23% to 31%, papillary lesions 16%, and radial scars 7%. Where there is doubt, histological confirmation should be sought by means of percutaneous biopsy. Conclusion: Benign breast changes can be definitively distinguished from malignant lesions through the selective use of available diagnostic investigations and interdisciplinary collaboration. When lesions of uncertain malignant potential are found (B3 in the biopsy classification), complete excision is indicated. Prospective studies on the early diagnosis of breast cancer in lesions carrying a risk of malignancy are desirable.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N